• Profile
Close

Association of noninfectious pneumonia with ustekinumab use

JAMA Dermatology Feb 20, 2019

Brinker A, et al. - In this study, investigators evaluated the FDA Adverse Event Reporting System (FAERS) and the PubMed databases from September 25, 2009, to November 20, 2017, to assess and identify post-marketing cases of noninfectious pneumonia correlated with ustekinumab use. They identified 12 cases: 7 interstitial pneumonia, 3 eosinophilic pneumonia, 1 organizing pneumonia, and 1 hypersensitivity pneumonitis diagnoses. They noted all the cases as a serious outcome, including 7 hospitalizations and 1 respiratory failure requiring mechanical ventilation. Findings suggested a correlation between noninfectious pneumonia and use of ustekinumab given that pulmonary symptoms were evident after 1-3 doses of ustekinumab in 75% of cases.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay